Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41591-020-0822-7 http://scihub22266oqcxt.onion/10.1038/s41591-020-0822-7 32284616!7094929!32284616     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nat+Med 2020 ; 26 (4): 506-510 Nephropedia Template TP {{tp|p=32284616|t=2020. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China |pdf=|usr=}}{{32284616}} gab.com Text Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China JO: Nat Med http://www.kidney.de/pget.php?&tw=1&pmid=32284616 #FOAvip As of 29 February 2020 there were 79,394 confirmed cases and 2,838 deaths from COVID-19 in mainland China. Of these, 48,557 cases and 2,169 deaths occurred in the epicenter, Wuhan. A key public health priority during the emergence of a novel pathogen is estimating clinical severity, which requires properly adjusting for the case ascertainment rate and the delay between symptoms onset and death. Using public and published information, we estimate that the overall symptomatic case fatality risk (the probability of dying after developing symptoms) of COVID-19 in Wuhan was 1.4% (0.9-2.1%), which is substantially lower than both the corresponding crude or naive confirmed case fatality risk (2,169/48,557 = 4.5%) and the approximator(1) of deaths/deaths + recoveries (2,169/2,169 + 17,572 = 11%) as of 29 February 2020. Compared to those aged 30-59 years, those aged below 30 and above 59 years were 0.6 (0.3-1.1) and 5.1 (4.2-6.1) times more likely to die after developing symptoms. The risk of symptomatic infection increased with age (for example, at ~4% per year among adults aged 30-60 years). Twit Text FOAVip Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China ????Nat Med http://www.kidney.de/pget.php?&tw=1&pmid=32284616 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32284616 #FOAvip English Wikipedia <ref>{{Cite pmid|32284616}}</ref> Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China #MMPMID32284616 Wu JT; Leung K; Bushman M; Kishore N; Niehus R; de Salazar PM; Cowling BJ; Lipsitch M; Leung GM Nat Med 2020[Apr]; 26 (4): 506-510 PMID32284616show ga As of 29 February 2020 there were 79,394 confirmed cases and 2,838 deaths from COVID-19 in mainland China. Of these, 48,557 cases and 2,169 deaths occurred in the epicenter, Wuhan. A key public health priority during the emergence of a novel pathogen is estimating clinical severity, which requires properly adjusting for the case ascertainment rate and the delay between symptoms onset and death. Using public and published information, we estimate that the overall symptomatic case fatality risk (the probability of dying after developing symptoms) of COVID-19 in Wuhan was 1.4% (0.9-2.1%), which is substantially lower than both the corresponding crude or naive confirmed case fatality risk (2,169/48,557 = 4.5%) and the approximator(1) of deaths/deaths + recoveries (2,169/2,169 + 17,572 = 11%) as of 29 February 2020. Compared to those aged 30-59 years, those aged below 30 and above 59 years were 0.6 (0.3-1.1) and 5.1 (4.2-6.1) times more likely to die after developing symptoms. The risk of symptomatic infection increased with age (for example, at ~4% per year among adults aged 30-60 years). |*Age Factors[MESH] |*Coronavirus Infections/complications/diagnosis/epidemiology[MESH] |*Models, Statistical[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/complications/diagnosis/epidemiology[MESH] |*Severity of Illness Index[MESH] |Adolescent[MESH] |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Asymptomatic Diseases[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |Child[MESH] |Child, Preschool[MESH] |China/epidemiology[MESH] |Clinical Laboratory Techniques[MESH] |Female[MESH] |Humans[MESH] |Infant[MESH] |Male[MESH] |Middle Aged[MESH] |Mortality[MESH] |Prognosis[MESH] |Real-Time Polymerase Chain Reaction[MESH] |Risk Factors[MESH]Estimating clinical severity of COVID-19 from the transmission dynamic(epmc).pdf DeepDyve Pubget Overpricing